MORGAN STANLEY PLC/CALL/AMGEN/480/0.1/20.06.25 | Market Closed - Bid/Ask 02:51:11 2024-05-22 pm EDT | After market 03:32:33 pm | |||
| 0.4 EUR | 0.00% |
|
0.415 | +3.75% |
| Current month | +76.21% | ||
| 1 month | +42.86% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-22 | 0.4 | 0.00% |
| 24-05-21 | 0.4 | -4.76% |
| 24-05-20 | 0.42 | +2.44% |
| 24-05-17 | 0.41 | -6.82% |
| 24-05-16 | 0.44 | -2.22% |
Delayed Quote Börse Stuttgart
Last update May 22, 2024 at 02:51 pm EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME6EUV |
| ISIN | DE000ME6EUV2 |
| Date issued | 2024-01-04 |
| Strike | 480 $ |
| Maturity | 2025-06-20 (394 Days) |
| Parity | 10 : 1 |
| Emission price | 0.25 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.56 € |
|---|---|
| Lowest since issue | 0.19 € |
| Spread | 0.03 € |
| Spread % | 6.98% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
314.8
USD
Average target price
316.1
USD
Spread / Average Target
+0.39%
- Stock Market
- Warrants
- Warrant
